| Literature DB >> 35607329 |
Golnoush Farzinnia1, Mehdi Sasannia2, Shima Torabi3, Fahimeh Rezazadeh4, Alireza Ranjbaran4, Azita Azad4.
Abstract
Objective: Proper diagnosis plays a key role in the treatment and prognosis of all diseases. Although histopathological diagnosis is still known as the gold standard, final diagnosis becomes difficult unless precise clinical descriptions are obtained. So, this study aimed to evaluate the concordance of the clinical and histopathological diagnoses of all oral and maxillofacial biopsy specimens in a 12-year duration. Materials andEntities:
Year: 2022 PMID: 35607329 PMCID: PMC9124151 DOI: 10.1155/2022/1016495
Source DB: PubMed Journal: Int J Dent ISSN: 1687-8728
Concordance rate of clinical and histopathologic diagnosis based on age ranges.
| Decade (age ranges) | Total cases | Concordance N (%) |
|
|---|---|---|---|
| 1 (0–9) | 4 | 2 (50%) | 0.520 |
| 2 (10–19) | 2797 | 2038 (72.6%) | |
| 3 (20–29) | 54 | 37 (68.5%) | |
| 4 (30–39) | 47 | 32 (68.1) | |
| 5 (40–49) | 31 | 16 (51.6%) | |
| 6 (50–59) | 41 | 32 (78%) | |
| 7 (60–69) | 18 | 12 (66.7%) | |
| 8 (70–79) | 6 | 5 (83.3%) | |
| 9 (80–89) | 2 | 2 (100%) | |
| 10 (90–99) | 1 | 1 (100%) |
Concordance rate of clinical and histopathologic diagnosis based on location.
| Site of lesion | Total cases | Concordance |
|
|---|---|---|---|
| Mandible | 770 | 516 (67%) | 0.040 |
| Maxilla | 495 | 346 (69.9%) | |
| Palate | 122 | 83 (68%) | |
| Alveolar mucosa | 80 | 56 (70%) | |
| Buccal mucosa | 479 | 399 (83.3%) | |
| Labial mucosa | 151 | 124 (82.1%) | |
| Ventral surface of tongue | 38 | 27 (71%) | |
| Dorsal surface of tongue | 100 | 77 (77%) | |
| Lateral surfaces of tongue | 190 | 130 (68.4%) | |
| Floor of mouth | 27 | 23 (85.2%) | |
| Gingiva | 410 | 271 (66.1%) | |
| Lip | 139 | 115 (82.7%) |
Concordance rate of clinical and histopathologic diagnosis based on the type of lesions.
| Category of lesion | Total cases | Concordance |
|
|---|---|---|---|
| Ulcerative, vesicular, and bullous lesions | 75 | 42 (56%) | 0.022 |
| Red and white lesions | 519 | 447 (86.1%) | |
| Pigmented lesions | 34 | 16 (47.1%) | |
| Exophytic soft tissue lesions | 1326 | 893 (67.3%) | |
| Bone lesions | 1047 | 769 (73.5%) |
Frequency and concordance rate of clinical and histopathologic diagnosis in each category of lesions.
| Lesion | Total cases | Concordance |
|---|---|---|
| Ulcerative, vesicular, and bullous lesions | ||
| Pemphigus vulgaris | 46 | 34 (73.9%) |
| Pemphigoid | 15 | 3 (20%) |
| Eosinophilic ulcers of tongue | 9 | 3 (33.3%) |
| Traumatic ulcers | 3 | 0 (0%) |
| Recurrent aphthous stomatitis | 1 | 1 (100%) |
| Erythema multiform | 1 | 1 (100%) |
|
| ||
| White and red lesions | ||
| Lichen planus | 449 | 398 (88.6%) |
| Leukoplakia | 63 | 49 (77.8%) |
| Oral erythroplakia | 4 | 0 (0%) |
| Lupus erythematosus | 2 | 0 (0%) |
| Hairy leukoplakia | 1 | 0 (0%) |
|
| ||
| Pigmented lesions | ||
| Oral/Labial melanotic macule | 14 | 11 (78.6%) |
| Inflammatory hyperpigmentation | 6 | 0 (0%) |
| Melanocytic nevus | 6 | 2 (33.3%) |
| Oral melanoacanthoma | 4 | 2 (50%) |
| Malignant melanoma | 3 | 1 (33.3%) |
| Melanosis | 1 | 0 (0%) |
|
| ||
| Exophytic soft tissue lesions1 | ||
| Reactive/Inflammatory lesions | 1100 | 742 (67.4%) |
| Fibroma | 361 | 247 (68.4%) |
| Pyogenic granuloma | 252 | 137 (54.4%) |
| Mucocele | 174 | 160 (91.9%) |
| Epulis fissuratum | 125 | 109 (87.2%) |
| Peripheral giant cell granuloma | 124 | 57 (46%) |
| Peripheral odontogenic fibroma | 38 | 18 (47.4%) |
| Epulis granulomatosa | 14 | 9 (64.3%) |
| Neurofibroma | 12 | 5 (41.7%) |
| Benign tumoral lesions | 83 | 43 (52%) |
| Oral papilloma | 50 | 33 (66%) |
| Pleomorphic adenoma | 15 | 5 (33.3%) |
| Lipoma | 5 | 0 (0%) |
| Schwannoma | 5 | 1 (20%) |
| Hemangioma | 4 | 0 (0%) |
| Traumatic neuroma | 2 | 2 (100%) |
| Lymphangioma | 1 | 1 (100%) |
| Basal cell adenoma | 1 | 1 (100%) |
| Malignant tumoral lesions | 143 | 108 (75.5%) |
| Squamous cell carcinoma | 132 | 104 (78.8%) |
| Basal cell carcinoma | 3 | 1 (33.3%) |
| Lymphoma | 3 | 0 (0%) |
| Mucoepidermoid carcinoma | 3 | 1 (33.3%) |
| Adenoid cystic carcinoma | 2 | 2 (100%) |
|
| ||
| Bone lesions2 | ||
| Cystic lesions | 861 | 669 (77.7%) |
| Radicular cyst | 420 | 358 (85.2%) |
| Odontogenic keratocyst | 184 | 115 (62.5%) |
| Dentigerous cyst | 173 | 134 (77.4%) |
| Residual cyst | 54 | 36 (66.7%) |
| Nasopalatine canal cyst | 18 | 18 (100%) |
| Traumatic bone cyst | 11 | 7 (63.6%) |
| Aneurysmal bone cyst | 1 | 1 (100%) |
| Benign tumoral lesions | 133 | 71 (53.4%) |
| Central giant cell granuloma | 50 | 26 (52%) |
| Ameloblastoma | 33 | 16 (48.5%) |
| Odontoma | 15 | 13 (86.7%) |
| Osteoma | 11 | 7 (63.6%) |
| Cementoblastoma | 7 | 4 (57.1%) |
| Adenomatoid odontogenic tumor | 7 | 1 (14.3%) |
| Central odontogenic fibroma | 1 | 1 (100%) |
| Odontogenic myxoma | 7 | 3 (42.9%) |
| Ameloblastic fibroma | 1 | 0 (0%) |
| Malignant tumoral lesions | 14 | 9 (64.3%) |
| Osteosarcoma | 11 | 6 (54.5%) |
| Fibrosarcoma | 2 | 2 (100%) |
| Chondrosarcoma | 1 | 1 (100%) |
| Other | 39 | 20 (51.2%) |
1. Exophytic lesions were subdivided into two subgroups: reactive/inflammatory and tumoral lesions (malignant and benign tumors). 2. Bone lesions were subdivided into two subgroups: cystic and tumoral lesions (malignant and benign tumors). Bone samples that were not included in either cystic or tumoral lesion were named “other”. This category includes developmental lesions of bone (fibrous dysplasia, ossifying fibroma, and periapical cemento-osseous dysplasia).